Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2011-03-01
2011-03-01
Leavitt, Maria (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C424S093700
Reexamination Certificate
active
07897588
ABSTRACT:
The present invention discloses agents and methods for inducing osteoblastic cellular differentiation, as well as the use of such agents and method to treat patients to maintain bone mass, enhance bone formation and/or bone repair. Exemplary agents include oxysterols, alone or in combination with particular oxysterols, or other agents known to assist in bone formation. The invention further includes medicaments including oxysterols for the treatment of bone disorders, local injections of oxysterols or cells (206) and implants (202) having agents or cells (203) to facilitate bone repair.
REFERENCES:
patent: 3887545 (1975-06-01), Iacobelli et al.
patent: 4183852 (1980-01-01), Kaiser
patent: 4743597 (1988-05-01), Javitt et al.
patent: 5929062 (1999-07-01), Haines
patent: 6080779 (2000-06-01), Gasper et al.
patent: 6184215 (2001-02-01), Elias et al.
patent: 6586189 (2003-07-01), Forman
patent: 6893830 (2005-05-01), Janowski et al.
patent: 2003/0153541 (2003-08-01), Dudley et al.
patent: 2004/0176423 (2004-09-01), Paralkar
patent: 2004/0235739 (2004-11-01), Mahanthappa
patent: 2005/0095677 (2005-05-01), Liu et al.
patent: 2006/0270645 (2006-11-01), Parhami
patent: 2 320 190 (1998-06-01), None
patent: WO 97/40137 (1997-10-01), None
patent: WO 00/54759 (2000-09-01), None
patent: WO 01/15676 (2001-03-01), None
patent: WO 02/080952 (2002-10-01), None
patent: WO 2004/019884 (2004-03-01), None
patent: WO 2005/028616 (2005-03-01), None
patent: WO/2005/020928 (2005-10-01), None
patent: WO/2006/012902 (2006-09-01), None
patent: WO 2006/110490 (2006-10-01), None
patent: WO/2007/098281 (2007-01-01), None
patent: WO 2007/028101 (2007-03-01), None
patent: WO 2008/041003 (2008-04-01), None
patent: WO 2008/115469 (2008-09-01), None
Larsson et al. “Kinetics of G1 progression in 3T6 and SV-3T3 cells following treatment by 25-hydroxycholesterol.” Cancer Res. Mar. 1986;46(3):1233-8.
Parish et al., Side-chain oxysterol regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A reductase activity, 1995, Lipids, pp. 247-251.
Wang et al., The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res. Jan. 2000;(370):295-310.
Garret et al., The role of statins as potential targets for bone formation. Arthritis Research, 2002, pp. 237-240.
International Search Report issued in PCT Application No. PCT/US07/05073, mailed on Oct. 29, 2007.
Written Opinion issued in PCT Application No. PCT/US07/05073, mailed on Oct. 29, 2007.
Nagano et al., Chemistry and Biochemistry of Chinese Drugs. Part II. Hydroxylated Sterols, Cytotoxic toward Cancerous Cells: Synthesis and Testing. J. Chem. Research, Apr. 1977, M, pp. 2522-2571, (With English Language Synopsis).
Wiersig et al., Stereospecific Synthesis of the Side Chain of the Steroidal Plant Sex Hormone Oogoniol. J. Org. Chem., (1979) vol. 44, No. 19, pp. 3374-3382.
Makino et al., Steroid Conformations in Solid and Solution: Stereoselectivity of Grignard Addition to 20-Keto Steroids, J. Org. Chem., (1978) vol. 43, No. 2, pp. 276-280.
Int'l Search Report for PCT/US03/27105, Mailed May 5, 2004.
Int'l Search Report for PCT/US04/28162, Mailed Feb. 22, 2005.
Hanada et al., Stimulatory Effects of Basic Fibroblast Growth Factor and Bone Morphogenetic Protein-2 Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells, J. Bone and Mineral Res. Oct. 1997, vol. 12, No. 10, pp. 1606-1614.
Thies et al., Recombinant Human Bone Morphogenetic Protein-2 Induces Osteoblastic Differentiation in W-20-17 Stromal Cells, Endocrinology 1992, vol. 130, No. 3, pp. 1318-1324.
Sammons et al., The Role of BMP-6, IL-6 and BMP-4 in Mesenchymal Stem Cell-Dependent Bone Development: Effects on Osteoblastic Differentiation Induced by Parathyroid Hormone and Vitamin D3, Jun. 2004, Stem Cells and Development vol. 13, pp. 273-280.
Aghaloo TL, Amantea CM, Cowan CM, Richardson JA, Wu BM, Parhami F, Tetradis S. Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo. J Orthop Res. Nov. 2007;25(11):1488-97 (also known as Aghaloo 2006 in press).
Akazawa C, Isuzuki H, Nakamura Y, Sasaki Y, Ohsaki K, Nakamura S, arakawa Y, Kohsaka S. The upregulated expression of sonic hedgehog in motor neurons after rat facial nerve axotomy. J Neuroscience 2004; 24:7923-7930.
Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. Dec. 16, 2005;280(50):41342-51.
Amantea CM et al. 2006, Oxysterols are novel activators of hedgehog and Wnt signaling, J Bone Miner Res 21:SI;S156.
Banerjee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, Lian JB. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem. Jul. 1, 1997;66(1):1-8.
Bannai K, Morisaki M, Ikekawa N. Studies on steroids. Part 37. Synthesis of the four stereoisomers of 20,22-epoxycholesterol. J Chem Soc Perkins Trans 1 1979; 2116-2120.
Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun. Oct. 19, 2001;288(1):275-9.
Beckers L, Heeneman S, Wang L, Burkly LC, Rousch MM, Davidson NO, Gijbels MJ, de Winther MP, Daemen MJ, Lutgens E. Disruption of hedgehog signalling in ApoE -/- mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophages. J Pathol. Aug. 2007;212(4):420-8.
Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A. Mar. 1, 2005;102(9):3324-9.
Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD, MacDougald OA. Regulation of Wnt signaling during adipogenesis. J Biol Chem. Aug. 23, 2002;277(34):30998-1004.
Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 1996; 11:568-577.
Bestmann HJ, Soliman FM. Synthesis and reaction of diazoacetyl chloride. Angew Chem 1979; 91:1012-1013.
Bijlsma MF, Peppelenbosch MP, Spek A. Hedgehog morphogen in cardiovascular disease. Circulation 114:1985-1991; 2006.
Bijlsma MF, Spek CA, Peppelenbosch MP. Hedgehog: an unusual signal transducer. BioEssays 26:387-394; 2004.
Bilezikian JP, Kurland ES. Therapy of male osteoporosis with parathyroid hormone. Calcif Tissue Int 2001; 69:248-251.
Bjorkhem I, Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol 22:734-742; 2002.
Bjorkhem I, Meaney S, Diczfalusy U. Oxysterols in human circulation: which role do they play? Curr Opion Lipidol 13:247-253; 2002.
Bjorkhem I, Reihner E, Angelin B, Ewerth S, Akerlund J, Einarsson K. On the possible use of the serum level of 7α-hydroxycholesterol as a marker for incrased activity of the cholesterol 7α-hydroxylase in humans. J Lipid Res 1987; 28:889-894.
Boguslawski G, Hale LV, Yu XP, Miles RR, Onyia JE, Santerre RF, Chandrasekhar S. Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways. J Biol Chem. Jan. 14, 2000;275(2):999-1006.
Boland GM, Perkins G, Hall DJ, Tuan RS. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem. Dec. 15, 2004;93(6):1210-30.
Braunersreuther V, Mach F. Leukocyte recruitment in atherosclerosis: potential targets for therapeutic approaches? Cell Mol Life Sci 63:2079-2088; 2006.
Bunta W, Yoshiaki N, Takehiko O, Hisashi M. Steroids 2004, 69: 483-493.
Burger A, Colobert F, Hetru C, Luu B. Tetrahedron 1988, 44: 1141-1152.
Byon C, Gut M. Stereospecific synthesis of the four 20,22-epoxycholesterols and of (Z)-20(22)-Dehydrocholesterol. J Org Chem 1976; 41:3716-3722.
Byrd N, Grabel L. Hedgehog signaling in murine vasculogenesis and angiogenesis. Trends Cardiovasc Med 14:308-313; 2004.
Ca
Axelrod Nancy J.
Gollin Michael A.
Leavitt Maria
The Regents of the University of California
Venable LLP
LandOfFree
Agents and methods for enhancing bone formation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agents and methods for enhancing bone formation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents and methods for enhancing bone formation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2759407